| pubmed-article:19098302 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19098302 | lifeskim:mentions | umls-concept:C0032533 | lld:lifeskim |
| pubmed-article:19098302 | lifeskim:mentions | umls-concept:C0039483 | lld:lifeskim |
| pubmed-article:19098302 | lifeskim:mentions | umls-concept:C0072027 | lld:lifeskim |
| pubmed-article:19098302 | lifeskim:mentions | umls-concept:C0033522 | lld:lifeskim |
| pubmed-article:19098302 | lifeskim:mentions | umls-concept:C0332162 | lld:lifeskim |
| pubmed-article:19098302 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19098302 | pubmed:dateCreated | 2009-1-14 | lld:pubmed |
| pubmed-article:19098302 | pubmed:abstractText | An epidemic pattern has been reported for GCA and PMR. Immunological studies have shown that an unknown antigen activates the dendritic cells of the adventitia and the type 4 toll-like receptors. Procalcitonin (PCT) is an early marker of bacterial infection. The goal of the study was to assess the level of PCT in GCA and PMR at the onset of the disease. | lld:pubmed |
| pubmed-article:19098302 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19098302 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19098302 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19098302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19098302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19098302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19098302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19098302 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19098302 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19098302 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19098302 | pubmed:issn | 1462-0332 | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:SchmidtJJ | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:MazièreJ CJC | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:DucroixJ PJP | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:SmailAA | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:SalleVV | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:DuhautPP | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:BetsouFF | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:ChatelainDD | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:BourgeoisA... | lld:pubmed |
| pubmed-article:19098302 | pubmed:author | pubmed-author:Groupe de... | lld:pubmed |
| pubmed-article:19098302 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19098302 | pubmed:volume | 48 | lld:pubmed |
| pubmed-article:19098302 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19098302 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19098302 | pubmed:pagination | 158-9 | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:meshHeading | pubmed-meshheading:19098302... | lld:pubmed |
| pubmed-article:19098302 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19098302 | pubmed:articleTitle | Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study. | lld:pubmed |
| pubmed-article:19098302 | pubmed:affiliation | Department of Internal Medicine, Place Victor Pauchet, Amiens University Hospital, 80000 Amiens CEDEX 1, France. schmidt.jean@chu-amiens.fr | lld:pubmed |
| pubmed-article:19098302 | pubmed:publicationType | Journal Article | lld:pubmed |
